Pfizer (PFE) in Global Blood Therapeutics (GBT) Takeover Talks
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
RBC Capital Steps Aside on Global Blood Therapeutics (GBT), 'Oxbryta Beat Confirms Value; With Solid Outcome'
August 8, 2022 4:19 PM EDTRBC Capital analyst Gregory Renza downgraded Global Blood Therapeutics (NASDAQ: GBT) from Outperform to Sector Perform with a price target of $68.50 (from $60.00).
The analyst comments "Srong Oxbryta revenue beat for 2Q22 and the PFE acquisition underscore the strong fundamentals... More
Pfizer (PFE) in Global Blood Therapeutics (GBT) Takeover Talks
August 5, 2022 11:54 AM EDTPfizer (NYSE: PFE) is reportedly in advanced talks to acquire Global Blood Therapeutics (NYSE: GBT), according to a report by The Wall Street Journal Friday.
The news follows Thursday's report by Bloomberg that large pharmaceutical companies... More
Global Blood Therapeutics (GBT) halted on volatility amid deal reports
August 5, 2022 11:36 AM EDTGlobal Blood Therapeutics (NASDAQ: GBT) halted on volatility amid deal reports
... MoreUPDATE: Pfizer (PFE) is in advanced talks to buy Global Blood Therapeutics (GBT) - WSJ
August 5, 2022 11:35 AM EDT(Updated - August 5, 2022 11:35 AM EDT)
Pfizer (NYSE: PFE) is in advanced talks to buy Global Blood Therapeutics (NASDAQ: GBT) - WSJ
the deal is said to be around $5 billion.... MoreIncreasing unusual call option volume: GBT XP AES ITUB FAZE NSC EVFM
August 5, 2022 2:31 AM EDTIncreasing unusual call option volume: GBT XP AES ITUB FAZE NSC EVFM
... MorePharmaceutical Giants Eye Global Blood Therapeutics Takeover - Bloomberg
August 4, 2022 12:58 PM EDTLarge pharmaceutical companies are reportedly eyeing a potential takeover deal for Global Blood Therapeutics (NASDAQ: GBT), according to a Bloomberg report Thursday.
Citing people familiar with the matter, the report states biopharmaceutical firm Global Blood Therapeutics is working with advisors to study potential interest, although there is no certainty a takeover will occur.... More
